Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

Share Price is delayed by 15 minutes
Get Live Data
50.55    0.00 (0.00%)
Bid:
49.60
Ask:
51.50
Spread: 1.90 (3.831%)
Market Cap: £193.32m
BSC Live PriceLast checked at - London Stock Exchange

Intraday Br.small Co.2 Share Chart

Dividend Declaration

17 Dec 2024 07:00

RNS Number : 2989Q
British Smaller Companies VCT2 Plc
17 December 2024
 

British Smaller Companies VCT2 plc ("the Company")

 

Special Interim Dividend

 

Following the successful realisation of the Company's investment in Traveltek in October 2024, the Directors are pleased to announce the payment of a special interim dividend for the year ending 31 December 2025 of 1.0 pence per ordinary share ("Special Interim Dividend").

 

The Special Interim Dividend will be paid on 27 January 2025 to those shareholders on the Company's register at the close of business on 27 December 2024. The ex-dividend date will be 24 December 2024. The 1.0 pence Special Interim Dividend will result in a corresponding reduction in the last reported net asset value to 54.85 pence per ordinary share.

 

The Company operates a dividend re-investment scheme ("DRIS"). The latest date for receipt of new or updated DRIS elections in respect of the Special Interim Dividend is the close of business on 13 January 2025.

 

Fundraising Update

In connection with the Company's 2024/25 joint £75 million new share offer with British Smaller Companies VCT plc, applications exceeding £63 million have been received to date, of which c. £25 million relate to the Company. The allotment of the first £25 million of gross proceeds will take place between 28 and 31 January 2025. The second and final allotment will take place between 1 and 4 April 2025. Funds awaiting allotment will receive additional shares equivalent to a 3.35 per cent per annum return (rate subject to change by the receiving agent's banking provider).

 

For further information, please contact:

 

Marcus Karia YFM Equity Partners Tel: 0113 244 1000

Alex Collins Panmure Liberum Tel: 0207 886 2767

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAXAKFDFLFFA
Date   Source Headline
24th Oct 20249:00 amRNSUpdate on Offers
24th Oct 20249:00 amRNSUpdate on Offers
17th Oct 20241:00 pmRNSPublication of Circular
17th Oct 202412:45 pmRNSPublication of a Prospectus
17th Oct 202412:45 pmRNSPublication of a Prospectus
27th Sep 20247:34 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSHalf-year Report
10th Sep 20242:00 pmRNSUpdate on new combined offer for subscription
20th Aug 20247:00 amRNSStatement re NAV and Proposed Fundraising
20th Aug 20247:00 amRNSStatement re NAV and Proposed Fundraising
28th Jun 20249:43 amRNSPayment of dividend and issue of shares
25th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 202412:30 pmRNSInterim Management Statement
13th Jun 202410:03 amRNSResult of AGM
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.